Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tuberculosis recovery in Georgia: implementing more by 24.
Kiria N, Lomtadze N, Solomonia N, Aspindzelashvili R, Danelia M, Gabisonia I, Janjgava M, Khonelidze I, Kipiani M, Tukvadze N, Blumberg HM, Kempker RR, Furin J, Avaliani Z. Kiria N, et al. Among authors: furin j. Lancet Infect Dis. 2023 Aug;23(8):893-894. doi: 10.1016/S1473-3099(22)00689-2. Epub 2022 Oct 27. Lancet Infect Dis. 2023. PMID: 36354031 Free PMC article. No abstract available.
A step in the right direction for children with tuberculosis.
Maugans C, Furin J. Maugans C, et al. Among authors: furin j. Lancet Infect Dis. 2023 Mar;23(3):268-269. doi: 10.1016/S1473-3099(22)00690-9. Epub 2022 Nov 14. Lancet Infect Dis. 2023. PMID: 36395781 No abstract available.
Balancing adjunctive therapy for tuberculosis treatment.
Ndjeka N, Furin J. Ndjeka N, et al. Among authors: furin j. Lancet Infect Dis. 2023 Jul;23(7):771-772. doi: 10.1016/S1473-3099(23)00136-6. Epub 2023 Mar 23. Lancet Infect Dis. 2023. PMID: 36966798 No abstract available.
Sustainable engagement.
Furin J. Furin J. Lancet. 2024 Jan 6;403(10421):20-21. doi: 10.1016/S0140-6736(23)02841-6. Lancet. 2024. PMID: 38184329 No abstract available.
The potential distraction of a pan-regimen approach to tuberculosis.
Rucsineanu O, Furin J. Rucsineanu O, et al. Among authors: furin j. Lancet Glob Health. 2024 Oct;12(10):e1565-e1566. doi: 10.1016/S2214-109X(24)00328-0. Epub 2024 Aug 16. Lancet Glob Health. 2024. PMID: 39159653 Free article. No abstract available.
Building social equity and person-centred innovation into the end TB response.
Engel N, Apolosi I, Bhargava A, Bhan A, Celan C, Mak A, Chikovore J, Chorna Y, Claassens MM, Dagron S, Denholm JT, Frick M, Furin J, Hoddinott G, Kashnitsky D, Kielmann K, Kunor T, Lin D, McDowell A, Mitchell EM, Oga-Omenka C, Samina P, Shikoli SA, Silva DS, Stein R, Stillo J, van der Westhuizen HM, Wingfield T, Zwerling A, Daftary A. Engel N, et al. Among authors: furin j. Int J Tuberc Lung Dis. 2024 Nov 1;28(11):517-520. doi: 10.5588/ijtld.24.0338. Int J Tuberc Lung Dis. 2024. PMID: 39468025
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis.
Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, Nardell EA, Warren RM; Lancet Respiratory Medicine drug-resistant tuberculosis Commission group. Dheda K, et al. Among authors: furin j. Lancet Respir Med. 2019 Sep;7(9):820-826. doi: 10.1016/S2213-2600(19)30263-2. Lancet Respir Med. 2019. PMID: 31486393 Review.
244 results